TWiV 957: Clinical update with Dr. Daniel Griffin

November 26, 2022

In his weekly clinical update Dr. Griffin discusses human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks, changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States, updates on COVID-19–related mortality, impact of community masking on COVID-19, effectiveness of the COVID-19 vaccines against hospitalization with Omicron sub-lineages BA.4 and BA.5 in England, cardiovascular outcomes after Tixagevimab and Cilgavimab use for pre-exposure prophylaxis against COVID-19, how Paxlovid is associated with decreased hospitalization rate among adults with COVID-19, inside the mind of an anti-paxxer, and angiotensin receptor blockers for the treatment of COVID-19.

Click arrow to play
Download TWiV 957 (26 MB .mp3, 43 min)
Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

2 comments on “TWiV 957: Clinical update with Dr. Daniel Griffin

  1. Blue Pilgrim Nov 26, 2022

    I’d like to hear about what is happening in China regarding Covid if or when you get some quality information — infection rate, severity, variant, herd immunity, vaccination, etc. I don’t think mainstream/corporate news is reliable, and that politics plays too big a part of it.

  2. Mary Chapin Nov 28, 2022

    Where are the links for the long covid articles mentioned?